Bristol-Myers Subpoenaed By SEC In FCPA Probe

Drug maker Bristol-Myers Squibb Co. said Thursday it received a subpoena from the Securities and Exchange Commission relating to a foreign bribery probe. More on Corruption Currents (WSJ). Read the 10-Q SEC filing . Bristol-Myers Squibb is a Global Compact participant since 2010/12/09. Bristol-Myers is a Gold Contributor to the Foundation for the Global Compact in 2012. It also contributed in 2011.